leisure time -WSS

leisure time

author：leisure time 2025-08-12 08:30:09 - browse：16

glum Benjamin — health insurance coverage from STAT — Adobe

Three biotech VC veterans, including one of the co-founders of radiopharma success story RayzeBio, are launching a new investment fund called Scion Life Sciences.

Scion was started by former Apple Tree Partners colleagues Sam Hall and Aaron Kantoff, along with Tadd Wessel, managing partner of the health care private equity firm Petrichor. They raised $310 million for its first fund, blowing past their original $250 million target.

They’re planning on taking a different tack with biotech venture capital. For starters, Scion plans to work on a significantly longer timeframe. Most firms in existence today write checks, help investments grow, and find a way to recoup their money in a 10-year timeframe. Scion is doubling that, setting a 20-year plan for its first fund.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： How AI can help patients find reliable information about doctors

WSS

STAT Summit: How researchers deal with rejection

CDC panel: People 65 and older should get a Covid spring booster shot

Readout Newsletter: Beam, Prozac, "TechBio" and more

Change Healthcare cyberattack shows risk of industry consolidation

Using force crossed my mind when examining a defiant young patient

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

hotspot

leisure time

leisure time

Jerome Adams on the need for new antivirals for Covid

STAT Summit: The economic case for universal basic health care

How to save PrEP access — and even expand it

STAT Summit: Meghan O’Rourke on making chronic illness visible

Affirmative action in medical school literally saved lives

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Heart attack and stroke risk calculators need revising

CDC panel: People 65 and older should get a Covid spring booster shot

Walensky prepares to leave CDC — and Congress — behind

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

explore

Virtual repurposing can help discover new uses for existing drugs

Children’s Hospital revives plan for pedestrian bridge

Readout LOUD podcast: Live from the 2023 STAT Summit

Ohio train derailment: Experts on toxic chemical risks

Questions loom on AstraZeneca cancer drug as safety concerns ebb

NEJM study measures Covid brain fog, impact on IQ

hotspot

leisure time

Wikipedia

focus